Should we screen for lung cancer in Australia?

Mark Hew, Robert G Stirling and Michael J Abramson
Med J Aust 2013; 199 (9): . || doi: 10.5694/mja13.11158
Published online: 4 November 2013

In reply: We welcome the opportunity to respond to correspondence from Marshall and colleagues and Mitchell and colleagues about the impact of the National Lung Screening Trial (NLST)1 on three distinct issues: (i) current medical practice; (ii) developing public health policy; and (iii) implementation of future screening.

  • Mark Hew1
  • Robert G Stirling1
  • Michael J Abramson2

  • 1 The Alfred, Melbourne, VIC.
  • 2 School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.